Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2017 Mar 23;26(7):1124–1132. doi: 10.1158/1055-9965.EPI-16-1007

Table 4.

Bivariate analysis for HRQOL differences by the prevalence of individual symptoms#

Physical HRQOL Mental HRQOL
Symptom presence No symptom presence Difference (95% CI) Symptom presence No symptom presence Difference (95% CI)
Sensation abnormality 49.37 55.43 −6.06*** (−6.58, −5.53) 50.99 55.69 −4.70*** (−5.26, −4.15)
Pain 49.04 57.90 −8.86*** (−9.35, −8.36) 51.37 56.85 −5.48*** (−5.97, −5.00)
Fatigue 50.00 57.76 −7.76*** (−8.28, −7.25) 51.68 57.17 −5.49*** (−6.03, −4.95)
Cognition disturbance 46.40 54.82 −8.42*** (−9.12, −7.71) 47.64 55.50 −7.86*** (−8.55, −7.18)
Depression 48.86 55.94 −7.08*** (−7.61, −6.55) 48.88 57.32 −8.44*** (−8.97, −7.89)
Anxiety 50.59 56.52 −5.93*** (−6.44, −5.43) 51.15 57.71 −6.56*** (−7.06, −6.06)
#

Numbers in the Table were weighted to represent the entire U.S. non-institutionalized adults.

Raw difference without covariate adjustment.

***

p<0.001.